Literature DB >> 16114498

Inhibition of P-glycoprotein by natural products in human breast cancer cells.

Soo Yeon Chung1, Min Kyung Sung, Na Hyung Kim, Jung Ok Jang, Eun Jung Go, Hwa Jeong Lee.   

Abstract

Multidrug resistance (MDR) is one of the most significant obstacles in cancer chemotherapy. One of the mechanisms involved in the development of MDR is the over-expression of P-glycoprotein (P-gp). It is widely known that natural compounds found in vegetables, fruits, plant-derived beverages and herbal dietary supplements not only have anticancer properties, but may also modulate P-gp activity. Therefore, the purpose of this investigation was to examine the effects of naturally occurring products on P-gp function in human breast cancer cell lines, MCF-7 (sensitive) and MCF-7/ADR (resistant). The accumulation of daunomycin (DNM), a P-gp substrate, was greater in the sensitive cells compared to the resistant cells, while the efflux of DNM was higher in the resistant cells compared to the sensitive cells over a period of 2 h. The IC50 value of DNM in the resistant cells was about 22 times higher than that in the sensitive cells, indicating an over-expression of P-gp in the resistant cells, MCF-7/ADR. All of the compounds tested, with the exception of fisetin, significantly decreased the IC50 value of DNM. Biochanin A showed the greatest increase in [3H]-DNM accumulation, increasing by 454.3 +/- 19.5% in the resistant cells, whereas verapamil, the positive control, increased the accumulation by 229.4 +/- 17.6%. Also, the accumulation of [3H]-DNM was increased substantially by quercetin and silymarin while it was reduced by fisetin. Moreover, biochanin A, silymarin, and naringenin significantly decreased DNM efflux from MCF-7/ADR cells compared with the control. These results suggest that some flavonoids such as biochanin A and silymarin may reverse MDR by inhibiting the P-gp function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16114498     DOI: 10.1007/BF02977349

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  22 in total

1.  Hesperidin as a preventive resistance agent in MCF-7 breast cancer cells line resistance to doxorubicin.

Authors:  Rifki Febriansah; Dyaningtyas Dewi Pamungkas Putri; Nunuk Aries Nurulita; Edy Meiyanto; Agung Endro Nugroho
Journal:  Asian Pac J Trop Biomed       Date:  2014-03

2.  Fisetin, a dietary bioflavonoid, reverses acquired Cisplatin-resistance of lung adenocarcinoma cells through MAPK/Survivin/Caspase pathway.

Authors:  Wenlei Zhuo; Liang Zhang; Yi Zhu; Bo Zhu; Zhengtang Chen
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 3.  Silymarin and epithelial cancer chemoprevention: how close we are to bedside?

Authors:  Manjinder Kaur; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-15       Impact factor: 4.219

4.  Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity.

Authors:  Ziyuan Wang; Long Zhang; Zhenhua Ni; Jian Sun; Hong Gao; Zhuoan Cheng; Jianhua Xu; Peihao Yin
Journal:  Tumour Biol       Date:  2015-07-01

5.  Flavonoid accumulation in Arabidopsis repressed in lignin synthesis affects auxin transport and plant growth.

Authors:  Sébastien Besseau; Laurent Hoffmann; Pierrette Geoffroy; Catherine Lapierre; Brigitte Pollet; Michel Legrand
Journal:  Plant Cell       Date:  2007-01-19       Impact factor: 11.277

6.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors:  Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Mol Signal       Date:  2010-08-18

7.  Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part II in vivo pharmacokinetics, antitumor efficacy and hepatotoxicity.

Authors:  Amit K Jain; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-10-18       Impact factor: 4.200

8.  Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.

Authors:  Rakesh K Srivastava; Su-Ni Tang; Wenyu Zhu; Daniel Meeker; Sharmila Shankar
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

9.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

10.  Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line.

Authors:  Jianguo Sun; Chilam Au Yeung; Ngai Na Co; Tsun Yee Tsang; Esmond Yau; Kewang Luo; Ping Wu; Judy Chan Yuet Wa; Kwok-Pui Fung; Tim-Tak Kwok; Feiyan Liu
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.